HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary M Marsh Selected Research

Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)

1/2019New insights into the mortality risk from nasopharyngeal cancer in the national cancer institute formaldehyde worker cohort study.
1/2016An updated re-analysis of the mortality risk from nasopharyngeal cancer in the National Cancer Institute formaldehyde worker cohort study.
1/2014Issues of methods and interpretation in the National Cancer Institute formaldehyde cohort study.
11/2010Incomplete follow-up in the National Cancer Institute's formaldehyde worker study and the impact on subsequent reanalyses and causal evaluations.
8/2007Work in the metal industry and nasopharyngeal cancer mortality among formaldehyde-exposed workers.
2/2007Mis-specified and non-robust mortality risk models for nasopharyngeal cancer in the National Cancer Institute formaldehyde worker cohort study.
8/2005Reevaluation of mortality risks from nasopharyngeal cancer in the formaldehyde cohort study of the National Cancer Institute.
7/2002Pharyngeal cancer mortality among chemical plant workers exposed to formaldehyde.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary M Marsh Research Topics

Disease

16Neoplasms (Cancer)
10/2019 - 01/2004
14Mesothelioma
01/2022 - 10/2003
8Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2019 - 07/2002
6Lung Neoplasms (Lung Cancer)
01/2018 - 06/2004
5Liver Neoplasms (Liver Cancer)
02/2021 - 03/2007
3Pharyngeal Neoplasms
01/2019 - 07/2002
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 05/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
02/2003 - 10/2002
1Breast Neoplasms (Breast Cancer)
10/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Malignant Mesothelioma
11/2017
1Inflammation (Inflammations)
05/2016
1Poisoning
01/2016
1Hepatocellular Carcinoma (Hepatoma)
09/2012
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
08/2009
1Bronchitis
08/2009
1Nervous System Diseases (Neurological Disorders)
10/2006
1Parkinsonian Disorders (Parkinsonism)
10/2006
1Parkinson Disease (Parkinson's Disease)
10/2006
1Leukemia
10/2004
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2004
1Pulmonary Edema
10/2003
1Hypertension (High Blood Pressure)
09/2002

Drug/Important Bio-Agent (IBA)

12Formaldehyde (Formol)FDA Link
08/2019 - 07/2002
8TalcFDA Link
01/2022 - 01/2017
8AsbestosIBA
01/2020 - 10/2003
5Formaldehyde poisoningIBA
08/2007 - 07/2002
4Vinyl Chloride (Chloroethylene)IBA
02/2021 - 03/2007
4CarcinogensIBA
01/2014 - 02/2003
3ChloropreneIBA
01/2021 - 03/2007
3CobaltIBA
12/2017 - 12/2017
3Pharmaceutical PreparationsIBA
01/2016 - 02/2005
3AcrylonitrileIBA
02/2015 - 06/2004
2Serpentine Asbestos (Chrysotile)IBA
01/2018 - 10/2011
2Particulate MatterIBA
01/2018 - 05/2016
2Amphibole AsbestosIBA
01/2018 - 10/2011
2TungstenIBA
12/2017 - 12/2017
2NickelIBA
12/2017 - 12/2017
2Urea (Carbamide)FDA LinkGeneric
01/2004 - 10/2002
1Ethylene Oxide (Oxirane)IBA
10/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1OzoneIBA
01/2018
1tungsten carbide (tungsten carbide (WC))IBA
12/2017
1Biological ProductsIBA
05/2016
1Biomarkers (Surrogate Marker)IBA
05/2016
1AflatoxinsIBA
09/2012
1Hemoglobins (Hemoglobin)IBA
06/2012
1Amosite Asbestos (Amosite)IBA
03/2012
1Mineral Fibers (Mineral Fiber)IBA
03/2012
1Crocidolite Asbestos (Blue Asbestos)IBA
03/2012
1tremolite (bredigite)IBA
10/2011
1CadmiumIBA
08/2009
1ArsenicIBA
08/2009
1SilverIBA
08/2007
1MetalsIBA
08/2007
1MineralsIBA
08/2007
1AcidsIBA
08/2007
1sulfuric acidIBA
08/2007
1ManganeseIBA
10/2006
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2004
12-Naphthylamine (2 Naphthylamine)IBA
02/2003
1Nitric AcidIBA
10/2002
1NitrogenIBA
10/2002
1insulin receptor-related receptor (IRR)IBA
09/2002

Therapy/Procedure

1Pleurodesis
01/2017